Practice
Specialties
Hygiene
Clinical
Business
Cases
Careers
Tariffs
Sign In
Endodontics
Oral & Maxillofacial Surgery
Orofacial Pain
Orthodontics
Pediatrics
Periodontics
Smile Design
Orofacial Pain: Page 177
Milestone Scientific announces leadership changes
By
DrBicuspid.com staff writers
Milestone Scientific has announced that Leslie Bernhard has been named chairman of the board. He succeeds Leonard Osser, who had served as chairman since 1991.
September 2, 2009
Propofol better than sevoflurane for pediatric patients?
By
DrBicuspid.com staff writers
Is propofol better than sevoflurane as a general anesthesia for pediatric patients?
September 2, 2009
Jurors weigh jaw risk of osteoporosis drug Fosamax
By
Reuters Health
NEW YORK (Reuters), Sep 3 - Jurors heard sharply different closing arguments on Wednesday in a trial over whether or not Merck & Co.'s Fosamax drug treatment for osteoporosis caused a Florida woman's jaw damage.
September 2, 2009
Articaine wins in mandibular infiltration study
By
Laird Harrison
Will mandibular infiltration ever replace the inferior alveolar nerve block? Researchers have been picking away at this question for years. An article in this month's
Journal of the American Dental Association
brought them another step closer to the answer.
August 26, 2009
Milestone Scientific gets notice of allowance on patent
By
DrBicuspid.com staff writers
The U.S. Patent and Trademark Office has issued a notice of allowance to Milestone Scientific for its U.S. patent application directed to the use of a disposable handpiece for fluid administration.
August 23, 2009
Komet develops diamond disk for ceramics
By
DrBicuspid.com staff writers
Komet USA has developed an innovative laboratory diamond disk suited for deflasking pressed ceramic material.
August 18, 2009
Lawyer recommends reporting drug-induced xerostomia to FDA
By
DrBicuspid.com staff writers
Dentists should report cases of xerostomia caused by medications to the FDA, Edwin Zinman, D.D.S., J.D., told attendees at the World Congress of Minimally Invasive Dentistry annual meeting.
August 18, 2009
Remedent Q1 sales drop 41%
By
DrBicuspid.com staff writers
Delays in the construction of a new production facility in China are being blamed for a 41% drop in Remedent's net sales for the first fiscal quarter of 2009.
August 13, 2009
Remedent debuts GlamStrip for GlamSmile veneers
By
DrBicuspid.com staff writers
Remedent has introduced GlamStrip, a proprietary, patent-pending device for the placement of its GlamSmile dental veneers.
August 13, 2009
OraPharma offers dental students Arestin training
By
DrBicuspid.com staff writers
OraPharma recently renewed the Arestin Student Access Program and created a new Professional Affairs Team to provide field support and instructor training for the program.
August 12, 2009
Milestone Scientific Q2 revenues up 52%
By
DrBicuspid.com staff writers
Milestone Scientific reported an increase of 52% in net revenues for the second quarter of this year.
August 11, 2009
New osteoporosis drug may avoid osteonecrosis
By
DrBicuspid.com staff writers
Denosumab, an investigational new drug for osteoporosis, increased patients' bone density without causing osteonecrosis of the jaw in a new study.
August 11, 2009
Previous Page
Page 177 of 193
Next Page